Form S-1
Please supplementally provide us with copies of all written communications, as defined in Rule 405 under the Securities Act, that you, or anyone authorized to do so on your behalf, present to potential investors in reliance on Section 5(d) of the Securities Act, whether or not they retain copies of the communications.
There have been no written communications as defined in Rule 405 to date. The Company acknowledges the Staff’s comment and respectfully advises the Staff that it will supplementally provide the Staff with copies of any and all future written communications as defined in
Rule 405 under the Securities Act. Read in the reply ↗
We note your disclosure that your offering of common shares will be at an "assumed public offering price." Please revise to state the price of the securities to the public and clarify whether it will be fixed for the duration of the offering. If you are not able to state a price, explain the method by which the price is to be determined. Refer to Instruction 2 to Item 501(b)(3) of Regulation S-K for guidance.
At the time of filing the
Registration Statement, the stock split ratio, the offering price and the number of shares to be offered was not known and still are not known. The Company will amend the Registration Statement when such information is determined. In the interim, the Amended Registration includes changes to the cover page which make clear that the offering price, once determined, will be fixed for the duration of the offering. Read in the reply ↗
We note your disclosure on page 104, under the heading Principal Stockholders, that your CEO, Jonathan Bates, controls 52.6% of your common stock and that your directors and executive officers, as a group, control 74.0% of your common stock.Rest of the question
Please advise as to whether you anticipate being a "controlled company," as defined by the rules of the exchange upon which you plan to list your shares, upon the completion of this offering, and provide appropriate disclosure on the prospectus cover page, prospectus summary and risk factors to the extent appropriate. In this regard, we note your risk factor disclosure on page 40. If applicable, please also clarify whether you will avail yourself of any controlled company exemptions to the relevant exchange’s corporate governance rules.
The Company respectfully acknowledges the Staff’s comment and has revised the Amended Registration Statement to clarify that the Company does not plan to elect treatment as a “controlled company,” as defined by the rules of any exchange where it plans to list its shares, even if it may technically meet the definition. However, the Company does not believe that additional disclosure of this risk is necessary because the offering terms currently being considered will result in Mr. Bates individually, and officers and directors as a whole, owning materially less than 50%.Read in the reply ↗Rest of the answer
However, if the final offering terms would possibly qualify the Company as a “controlled company,” the Company will add the additional disclosure suggested in the comment.
Your cover page disclosure indicates that the listing of your common stock on a national securities exchange or trading market is a condition to this offering. If so, please reconcile your disclosure here to indicate that your offering is contingent upon such listing.
This risk factor, and certain other disclosures in the Amended Registration Statement, have been amended to clarify that the offering is contingent on the approval of such listing. Read in the reply ↗
Please revise this risk factor to disclose the number of shares of common stock the
In response to the Staff’s comment, the risk factor has been amended to specify the number of shares of common stock that will be issued upon conversion of the two series of preferred stock on both a preand post-split basis. Read in the reply ↗
Please tell us whether a material part of the proceeds of this offering will be used to discharge your indebtedness to IDI. If so, please revise to disclose the interest rate and maturity of such indebtedness. Additionally, describe the use of the proceeds of such indebtedness, or advise. Refer to Instruction 4 to Item 504 of Regulation S-K.
None of the proceeds will be used to discharge the Company’s debt to IDI, and therefore we do not believe any change is necessary to the “Use of Proceeds” section. The manner in which the IDI debt will be restructured is fully disclosed in “Management’s Discussion and Analysis of Financial Condition and Results of Operation – Liquidity and Capital Resources” and “Certain Relationships and Related Party Transactions – Letter Agreement with Jonathan Bates and IDI,” which sections make clear that no cash payment will be made to IDI as part of the restructuring of the IDI debt. Read in the reply ↗
Please expand your disclosure related to the line of credit from IDI to disclose the largest aggregate amount of principal outstanding during the period for which disclosure is provided, the amount of principal paid during the periods for which disclosure is provided, and the amount of interest paid during the period for which disclosure is provided.Rest of the question
Please make corresponding revisions to your risk factor disclosure on page 44.
In response to the Staff’s comment, the passage described above has been amended to clarify that the Company had not made any payment of principal or accrued interest under the LOC Agreement since its inception and, as a result, the current principal and interest amount represents the largest amounts that have been outstanding since the Company’s entry into the loan agreement. Read in the reply ↗
Please revise your disclosure to also show the beneficial ownership information after the completion of the offering. We also note that you intend to effectuate a Reverse Split immediately following the effective date of the registration statement but prior to the closing of this offering. Please clarify if the information presented in this section reflects the Reverse Split.
In response to the Staff’s comment, the beneficial ownership table has been amended to add additional columns showing the number of shares, and the percentage ownership, of each person listed therein after giving effect to the stock split and the offering.
In connection with responding to the Staff’s comments, we acknowledge that:
· the Company is responsible for the adequacy and accuracy of the disclosure in the filing;
Staff comments or changes to disclosure in response to Staff comments do not foreclose the Commission from taking any action with respect to the filing; and the CompanyRead in the reply ↗Rest of the answer
may not assert Staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
We note that your registration statement includes a number of blanks or omitted information, including, without limitation: • the exchange on which your common stock will be listed; • the number of shares that will be available for sale into the market if the restrictions under the lock-up agreements with your directors, executive officers and holders of 5% or more of your common stock are waived (page 48); and •Rest of the question
certain information related to the annual management fee and performance allocation IDI is entitled to pursuant to the line of credit (pages 73 and 102). Please include this information in your next amendment, or tell us when you intend to do so.
The
Company acknowledges the Staff’s comment and respectfully responds as follows:
· The Company expects to list its common stock on the NYSE American and has filed an application for such listing. The Registration Statement has been amended to disclose the NYSE American as the prospective stock exchange for the Company’s common stock.
· The risk factor on page 49 has been amended to disclose the number of shares that will be available for sale if the restrictions under the lock-up agreements with the Company’s directors, executive officers, and holders of 5% or more of its common stockRead in the reply ↗Rest of the answer
are waived.
· The disclosures on pages 76 and 108 have been revised to clarify that the general partner of IDI is entitled to an annual management fee of 0% on net assets of the partnership and an annual performance allocation of 30% on the increase in the net asset value of the partnership.
We note in the first paragraph that you are offering 1,704,546 shares of your common stock. Please revise here and throughout your Prospectus to also disclose the total number of shares you are offering assuming the underwriters exercise the overallotment option in full.
In response to the Staff’s comment, the Registration Statement has been amended to disclose the total number of shares offered in the offering assuming the underwriters exercise the overallotment option in full. Read in the reply ↗
Please revise to disclose the total number of shares of your common stock outstanding giving effect to the anticipated conversion of your Series A and B preferred stock and indebtedness due to an affiliate. Please make similar revisions to your disclosure in the second paragraph on page 104 under Principle Stockholders and elsewhere in your Prospectus, as appropriate.
The Company acknowledges the Staff’s comment and respectfully advises the Staff that the conversion numbers were added to the total number of shares of common stock outstanding after the offering and disclosed in footnote 2 on pages 13 and 111. This is because the conversions will occur upon consummation of the offering, i.e., the offering has to occur first before the conversions will occur. It could be misleading to include the conversions in the number of shares outstanding prior to the offering. However, if the Staff disagrees, we are happy to make this revision upon your further comment. Read in the reply ↗
Please revise this risk factor to disclose, on a post-split basis, the number of shares of common stock the shares of Series A Convertible Preferred Stock are convertible into, the number of shares of common stock the shares of Series B Convertible Preferred Stock are convertible into, and the total of the two.
In response to the Staff’s comment, the risk factor has been amended to disclose on a post-split basis, the number of shares of common stock the shares of Series
A Convertible Preferred Stock are convertible into, the number of shares of common stock the shares of Series B Convertible Preferred
Stock are convertible into, and the total of the two. Read in the reply ↗